Aveanna Healthcare (AVAH)
(Delayed Data from NSDQ)
$2.57 USD
+0.04 (1.58%)
Updated Jul 10, 2024 04:00 PM ET
2-Buy of 5 2
A Value A Growth B Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
AVAH 2.57 +0.04(1.58%)
Will AVAH be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for AVAH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AVAH
Compared to Estimates, Aveanna (AVAH) Q1 Earnings: A Look at Key Metrics
Aveanna Healthcare (AVAH) Reports Q1 Loss, Tops Revenue Estimates
AVAH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Countdown to Aveanna (AVAH) Q1 Earnings: Wall Street Forecasts for Key Metrics
Addus HomeCare (ADUS) Q1 Earnings and Revenues Beat Estimates
Aveanna (AVAH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Other News for AVAH
Aveanna Healthcare Enhances Investor Communication with Presentation
Aveanna to Participate at the UBS Healthcare Services Cape Cod Summit and Jefferies Global Healthcare Conference
Truist Financial Sticks to Their Hold Rating for Aveanna Healthcare Holdings (AVAH)
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Oncolytics Biotech (ONCY), Aveanna Healthcare Holdings (AVAH) and Sanofi (OtherSNYNF)
Polen Capital Q1 2024 Credit Opportunities Full Discretion Composite Commentary